sinus severe

Generic: acetaminophen, guaifenesin, and phenylephrine hydrochloride

Labeler: chain drug consortium
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name sinus severe
Generic Name acetaminophen, guaifenesin, and phenylephrine hydrochloride
Labeler chain drug consortium
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

acetaminophen 325 mg/1, guaifenesin 200 mg/1, phenylephrine hydrochloride 5 mg/1

Manufacturer
CHAIN DRUG CONSORTIUM

Identifiers & Regulatory

Product NDC 68016-504
Product ID 68016-504_2433dde9-0eed-313a-e063-6294a90a9441
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Marketing Start 2009-11-01
Marketing End 2026-07-31

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68016504
Hyphenated Format 68016-504

Supplemental Identifiers

RxCUI
1243679
UPC
0840986024962
UNII
362O9ITL9D 495W7451VQ 04JA59TNSJ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sinus severe (source: ndc)
Generic Name acetaminophen, guaifenesin, and phenylephrine hydrochloride (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
  • 200 mg/1
  • 5 mg/1
source: ndc
Packaging
  • 2 BLISTER PACK in 1 CARTON (68016-504-24) / 12 TABLET, COATED in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (3)

acetaminophen (325 mg/1) guaifenesin (200 mg/1) phenylephrine hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2433dde9-0eed-313a-e063-6294a90a9441", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0840986024962"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["01a1183d-deec-40ca-94da-a6e40b7af2c7"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CHAIN DRUG CONSORTIUM"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (68016-504-24)  / 12 TABLET, COATED in 1 BLISTER PACK", "package_ndc": "68016-504-24", "marketing_end_date": "20260731", "marketing_start_date": "20091101"}], "brand_name": "Sinus Severe", "product_id": "68016-504_2433dde9-0eed-313a-e063-6294a90a9441", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "68016-504", "generic_name": "ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE", "labeler_name": "CHAIN DRUG CONSORTIUM", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Sinus Severe", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260731", "marketing_start_date": "20091101"}